Aspire-Lakewood Holdings, Inc. (ASBP): Total Liabilities
$7.69M
As of 2025-12-31
$1.78M
As of 2026-06-30
-11.6%
3-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.69M | +355.5% | 2026-04-08, Balance as of period end |
| 2024-12-31 | $1.69M | +318.5% | 2026-04-08, Balance as of period end |
| 2023-12-31 | $403.3K | -96.4% | 2025-04-07, Balance as of period end |
| 2022-12-31 | $11.12M | n/m | 2024-03-11, Balance as of period end |
| 2021-12-31 | $293.7K | n/a | 2023-03-21, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Aspire-Lakewood Holdings, Inc. (ASBP) | 2025-12-31 | $7.69M | +355.5% |
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | $813.0K | +17.5% |
| Genelux Corp (GNLX) | 2025-12-31 | $7.48M | -11.4% |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | $2.71M | +0.3% |
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | $2.36M | +36.5% |
| Skinvisible, Inc. (SKVI) | 2025-12-31 | $10.39M | +10.8% |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | $7.40M | +264.3% |
| Talphera, Inc. (TLPH) | 2025-12-31 | $12.68M | +23.9% |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | $1.85M | -85.8% |
Compare ASBP, TCRT, GNLX, PRFX side by side · Screen every company in Pharmaceutical Preparations ↗